Amanda Markovitz

Amanda Markovitz’s research interests include studying innovative approaches for delivering primary care, evaluating alternative payment models, improving chronic disease prevention and management, and analyzing population health.

Since joining Mathematica in 2018, Markovitz has led several quantitative evaluations of innovative programs and care delivery models. Currently, she leads the impact team to study the effects of CMS’s Million Hearts Cardiovascular Disease Risk Reduction Model on heart attacks and strokes and other outcomes using linked Medicare claims, clinical registry data, and cause-of-death data from the National Death Index. She also leads the quantitative evaluation of CDC’s WISEWOMAN program to determine whether the cardiovascular risk-reduction program is associated with changes in health outcomes, behaviors, and health disparities. Previously, she led tasks to evaluate CMS’s Comprehensive Primary Care Plus, including synthesizing results from implementation and impacts evaluation findings and analyzing the impacts of COVID-19 on evaluation results.

Markovitz also leads projects aimed at improving population health. She currently leads the research team to support the National Kidney Foundation of Michigan's Morris Hood III Chronic Kidney Disease Prevention Initiative, by providing analytics and data visualizations that help the foundation prevent and slow the progression of chronic kidney disease. She also directs a project to identify possible data sources and elements that could be used by CDC to build a surveillance system to identify children with fetal alcohol spectrum disorders. Recently, she also directed a team to write a report detailing the state of Massachusetts’s response to prevent transmission of COVID-19 in long-term care facilities.

Markovitz is trained in epidemiology and biostatistics and has a doctorate in epidemiology from the Harvard School of Public Health. Prior to Mathematica, she spent four years working at Blue Cross Blue Shield of Michigan designing and evaluating physician incentive programs.